Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00130572Phase 3Completed
Phase 3, randomised trial in oral lichen planus (OLP) comparing Pimecrolimus with Placebo (2 arms). Primary endpoint: Reduction of a symptom score. Started Jun 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00130572.